CLINICS 2012;67(7):821-826 3. Hale SL, Alker KJ, Rezkalla S, Figures G, Kloner RA. Adverse effect of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model. Am Hearth J. 1989;118(5 Pt 1):927-33. 4. Aslibekyan S, Levitan EB, Mittleman MA. Prevalent Cocaine Use and Myocardial Infarction. Am J Cardiol. 2008;102(8):966-9, http:// dx.doi.org/10.1016/j.amjcard.2008.06.016. 5. Ross GS, Bell J. Myocardial infarction associated with inappropriate use of topical cocaine as treatment for epistaxis. Am J Emerg Med. 1992;10(3):219-22, http://dx.doi.org/10.1016/0735-6757(92)90213-H. 6. Osula S, Stockton P, Abdelaziz MM, Walshaw MJ. Intratracheal cocaine induced myocardial infarction: an unusual complication of fibreoptic bronchoscopy. Thorax. 2003;58(8):733-4, http://dx.doi.org/10.1136/ thorax.58.8.733. 7. Makaryus JN, Makaryus AN, Johnson M. Acute myocardial infarction following the use of intranasal anesthetic cocaine. South Med J. 2006;99(7):759-61, http://dx.doi.org/10.1097/01.smj.0000223951.68627.32. 8. Montisci M. Cannabis and cocaine: a lethal cocktail triggering coronary sudden death. Cardiovascular Pathology. 2007;17(5):344-6. 9. Krantz MJ, Rowan SB, Mehler PS. Cocaine-related torsade de pointes in a methadone maintenance patient. J Addict Dis. 2005;24(1):53-60, http:// dx.doi.org/10.1300/J069v24n01_05. 10. Geggel RL, McInerny J, Estes NAM. Tansient neonatal ventricular tachycardia with maternal cocaine use. Am J Cardiol. 1989;63(5):383-4, http://dx.doi.org/10.1016/0002-9149(89)90359-7. 11. McCann B, Hunter M, Mccann J. Cocaine/heroin induced rabdomyolisis and ventricular fibrillation. Emerg Med J. 2002;19(3):264-5, http:// dx.doi.org/10.1136/emj.19.3.264. 12. Shereif H, Rezkalla MD, Kloner RA. Cocaine-induced acute myocardial infarction. Clin Med and Research. 2007;5(3):172-6. 13. Mittlemann MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine. Circulation. 1999; 99(21):2737-41. 14. Kerns W II, Garvey L, Owens J. Cocaine- induced wide complex dysrythmia. J Emerg Med. 1995;15(3):321-9. 15. Kanami PM, Guse PA, Smith WM, Barnett A, Ellinwood EHJr. Acute deleterious effects of cocaine on cardiac conduction, hemodynamics and ventricular fibrillation thresholds: effects on interaction with a selective dopamine D1 antagonist SCH39166. J Cardiovasc Pharmacol. 1998;32(1):42-8, http://dx.doi.org/10.1097/00005344-199807000-00007. 16. Mitlemann MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by Marijuana. Circulation. 2001; 103(23):2805-9. 17. Qureshi Al, Suri MF, Guterman LR, Hopkins LN. Cocaine se and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation. 2001;103(4):502-6. 18. Hollander JE, Shih RD, Hoffmann RS, Harchelroad FP, Philips S, Brent J. Predictor of coronary artery disease in patients with cocaine-associated myocardial infarction. Cocaine-Associated Myocardial Infarction (CAMI) Study Group. Am J Med. 1997;102(2):158-63, http://dx.doi.org/ 10.1016/S0002-9343(96)00406-8. 19. Yu SL, LIU CP, Lo YK, Shoa-Lin S. Acute Myocardial infarction after heroin injections. Jpn Heart J. 2004;45(6):1021-8. 20. Paterna S, Di Pasquale P, Montaina G, Procaccianti P, Antona A, Scaglione R, et al. Effect of heroin and morphine on cardiac performance in isolated and perfused rabbit hearth: valuation of cardiac hemody- namics, myocardial enzyme activity and ultrastructure features. Cardiologia. 1991;36(10):811-5. 21. Schwartzfarb L, Singh G, Marcus D. Heroin- associated rhabdomyolisis with cardiac involvement. Arch Intern Med. 1977;137(9):1255-7, http:// dx.doi.org/10.1001/archinte.1977.03630210121035. 22. Sztajzel J, Karpuz H, Rutishauser W. Heroin abuse and myocardial infarction. Int J Cardiol. 1994;47(2):180-2, http://dx.doi.org/10.1016/ 0167-5273(94)90187-2. 23. Schwartz RH. Adolescent heroin use: a review. Pediatrics. 1998; 102:1461-6, http://dx.doi.org/10.1542/peds.102.6.1461. 24. Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J. 1973;86(6):663-8, http:// dx.doi.org/10.1016/0002-8703(73)90344-X. 25. Silverma SH, Turner WW Jr. Intraarterial drug abuse: new treatment options. J Vac Surg. 1991;14(1):111-6, http://dx.doi.org/10.1016/0741- 5214(91)90162-N. 26. Bartolomei F, Nicoli F, Swiader L, Gastaut JL. Ischemic cerebral vascular stroke after heroin sniffing. A new case. Press Med. 1992;21(21):983-6. 27. Adle-Biassette H, Marc B, Benhaiem-Sigaux N, Durigon M, Gray F. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):7-12. 28. Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta. 2009;1793(6):993-1007, http:// dx.doi.org/10.1016/j.bbamcr.2008.11.016. 29. Li DR, Ishikawa T, Zhao D, Michiue T, Maeda H. Postmortem serum protein S100B levels with regard to the cause of death involving brain 825 Cardiac changes following overdose Faa A et al. damage in medicolegal autopsy cases. Legal Medicine. 2006;8(2):71-7, http://dx.doi.org/10.1016/j.legalmed.2005.07.004. 30. Wunderlich MT, Wallesch CW, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J of the Neurological sciences. 2004;227(1):49-53, http://dx.doi.org/10.1016/ j.jns.2004.08.005. 31. Weiss N, Sanchez Pena P, Roche S, Beaudeux JL, Colonne C, Coriat P, et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology. 2006;104(4):658-66, http://dx. doi.org/10.1097/00000542-200604000-00008. 32. Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encefalopathy in asphyxiated full- term infants. Crit Care Med. 2004;32(1):131-6, http://dx.doi.org/ 10.1097/01.CCM.0000104116.91462.CD. 33. Johnsonn P, Backstrom M, Bergh C, Jonsonn H, Luhrs C, Alling C. Ann Thorac Surg. 2003;75(1):162-8. 34. Gazzolo D, Florio P, Ciotti S, Marinoni E, di Iorio R, Bruschettini M, et al. S100B protein in urine of preterm newborns with ominous out come. Pediatrich Research. 2005;58(6):1170-5, http://dx.doi.org/10.1203/ 01.pdr.0000185131.22985.30. 35. Braga CW, Martinez D, Wofchuk S, Portela SV, Souza DO. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Medicine. 2006;7(5):431-35, http://dx.doi.org/10.1016/j.sleep.2005.12.012. 36. Haimoto H, Hosoda S, Kato K. Differential distribution of immunor- eactive S100A and S100 B proteins in normal non nervous human tissues. Laboratory Investigations. 1987;57(5):489-97. 37. O Kleine T, Benes L, Zofel P. Studies of the brain specificity of S 100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Research Bulletin. 2003;61(3):265-79, http://dx.doi.org/10.1016/ S0361-9230(03)00090-X. 38. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hilbom M. Effects of head and extracranial injuries on serum protein S100B level in trauma patients. J Trauma. 2004;56:1229-1234, http://dx.doi.org/10.1097/ 01.TA.0000096644.08735.72. 39. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzong R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48(6):1255-8; discussion 1258-60. 40. Mazzini GS, Schaf DV, Oliveira A, Goncalves CA, Bello-Klein A, Bordignon S et al. The ischemic rat heart releases S100B. Life Sciences. 2005;77(8):882-9, http://dx.doi.org/10.1016/j.lfs.2004.12.035. 41. Ambrozic J, Bunc M, Osredkar J, Brvar M. S100b protein in benzodia- zepine overdose. Emergency Medical Journal. 2008;25(2):90-2. 42. Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Jochum M. S-100B, SE-selectin and P-selectin for avaluation of hypoxic brain damage in patients after cardiopulmonary resuscitation: pilot study. World J Surg. 2001;25(5):539-43; discussion 544. 43. Tsoporis JN, Marks A, Kahn HJ, Butany JW, Liu PP, O’Hanlon D, et al. Inhibition of norepinephrine-induced cardiac hypertrophy in S100B transgenic mice. J Clin Invest. 1998;102(8):1609-16, http://dx.doi.org/ 10.1172/JCI3077. 44. Tramontina AC, Tramontina F, Bobermina LD, Zanotto C, Souza DF, Leite MC, et al. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008;32(6):1580-3, http://dx.doi.org/10.1016/j.pnpbp.2008.06.001. 45. Polettini A, Poloni V, Groppi A, Stramesi C, Vignali C, Politti L. The role of cocaine in heroin-related deaths Hypothesis on the interaction between heroin and cocaine. Forensic Science International. 2005;153(1):23–8, http://dx.doi.org/10.1016/j.forsciint.2005.04.017. 46. Hsieh CH, Davis ME, Lisowsky LK, Lee LT. Endothelial-cardiomyocytes interactions in cardiac development and repair. Ann. Rev. Phisiol. 2006; 68:51-66, http://dx.doi.org/10.1146/annurev.physiol.68.040104.124629. 47. Tsoporis JN, Marks A, Haddad A, Dawood F, Liu PP, Parker TG. S100b expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation. 2005;111(5):598-606, http://dx.doi.org/ 10.1161/01.CIR.0000154554.65287.F5. 48. Deloulme JC, Raponi E, Gentil BJ, Bertacchi N, Marks A, Labourdette G, et al. Nuclear expression of S100B in oligodendrocytes progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol Cell Neurosc. 2004;27(4): 453-65, http://dx.doi.org/10.1016/j.mcn.2004.07.008. 49. Bloomfield SM., McKinney J, Smith L, Brisman J. Reliability of S100b in predicting severity of central nervous system injury. Neurocrit Care. 2007;6(2):121-38, http://dx.doi.org/10.1007/s12028-007-0008-x. 50. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory response. J Clin Invest. 2001;108(7):949-55. 51. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B et al. Understanding Rage, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876-86, http://dx.doi.org/ 10.1007/s00109-005-0688-7.